Authors

• Jeppe Thagaard (ORCID: https://orcid.org/0000-0003-0201-2243)
• Suzanne Parry
• David J. Dabbs (ORCID: https://orcid.org/0000-0002-5569-552X)
• Jing Yu (ORCID: https://orcid.org/0000-0001-5331-6226)
• Bharat Jasani
• Mary Kinloch (ORCID: https://orcid.org/0000-0002-0092-0312)
• Stephen P. Naber (ORCID: https://orcid.org/0000-0002-2143-3919)
• Kodela Vani
• Seshi R. Sompuram
• Luis Chiriboga (ORCID: https://orcid.org/0000-0002-2028-6873)
• Beth Z. Clark (ORCID: https://orcid.org/0000-0001-5965-8294)
• Henrik Høeg
• Yukako Yagi
• Catherine T. Stoos
• Nils t'Hart
• Steve Bogen
• Emina Torlakovic (ORCID: https://orcid.org/0000-0003-1856-9804)
• Mélissande Cossutta (ORCID: https://orcid.org/0000-0001-5460-8386)
• F. Soussaline
• Alexandre Papine
• Søren Nielsen (ORCID: https://orcid.org/0000-0002-4414-2508)
• Keith Miller (ORCID: https://orcid.org/0000-0002-6662-7629)
• Matthias Szabolcs
• James Sayre

Institutions

• Boston Medical Center (US)
• Tufts Medical Center (US)
• Memorial Sloan Kettering Cancer Center (US)
• University of California, Los Angeles (US)
• Saskatchewan Health Authority (CA)
• Columbia University Irving Medical Center (US)
• Aalborg University Hospital (DK)
• Nebraska Methodist College (US)
• Royal University Hospital (CA)
• Imstar (France) (FR)
• University of Pittsburgh Medical Center (US)
• Isala (NL)
• CRUK Lung Cancer Centre of Excellence (GB)
• Steel Construction Institute (GB)
• University College London (GB)
• New York University (US)
• Cardiff University (GB)
• Aalborg University (DK)

Publication Details

Journal

EBioMedicine

Published

2025-09-12

DOI

https://doi.org/10.1016/j.ebiom.2025.105919

Citations

5

Primary Topic

HER2/EGFR in Cancer Research

Type

article

Field-Weighted Citation Impact

5.23

Funders

• National Institutes of Health
• National Cancer Institute